MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ANTX has $61,950K in assets. $8,890K in debts. $19,941K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
687.35%
Quick Ratio
687.35%
Cash Ratio
228.68%
Debt to Asset Ratio
14.35%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Long-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
19,941
Short-term investments
38,060
Prepaid expenses and other current assets
1,936
Total current assets
59,937
Long-term investments
2,013
Other assets, long-term
0
Total assets
61,950
Accounts payable
3,021
Accrued compensation
2,418
Accrued liabilities
2,052
Other current liabilities
1,229
Total current liabilities
8,720
Other non-current liabilities
170
Total liabilities
8,890
Additional paid-in capital
293,953
Accumulated other comprehensive gain
57
Accumulated deficit
-240,950
Total stockholders' equity
53,060
Total liabilities and stockholders' equity
61,950
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$38,060K Cash and cashequivalents$19,941K Prepaid expenses andother current assets$1,936K Total current assets$59,937K Long-term investments$2,013K Total assets$61,950K Total liabilities andstockholders' equity$61,950K Total stockholders'equity$53,060K Total liabilities$8,890K Accumulated deficit-$240,950K Additional paid-in capital$293,953K Total currentliabilities$8,720K Other non-currentliabilities$170K Accumulated othercomprehensive gain$57K Accounts payable$3,021K Accrued compensation$2,418K Accrued liabilities$2,052K Other currentliabilities$1,229K

AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics, Inc. (ANTX)